Cargando…

Neurocognitive Features of Motor Premanifest Individuals With Myotonic Dystrophy Type 1

OBJECTIVE: The goal of the study was to identify brain and functional features associated with premanifest phases of adult-onset myotonic dystrophy type 1 (i.e., PreDM1). METHODS: This cross-sectional study included 68 healthy adults (mean age = 43.4 years, SD = 12.9), 13 individuals with PreDM1 (me...

Descripción completa

Detalles Bibliográficos
Autores principales: van der Plas, Ellen, Koscik, Timothy R., Magnotta, Vincent, Cumming, Sarah A., Monckton, Darren, Gutmann, Laurie, Nopoulos, Peggy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8075572/
https://www.ncbi.nlm.nih.gov/pubmed/33912661
http://dx.doi.org/10.1212/NXG.0000000000000577
_version_ 1783684542018617344
author van der Plas, Ellen
Koscik, Timothy R.
Magnotta, Vincent
Cumming, Sarah A.
Monckton, Darren
Gutmann, Laurie
Nopoulos, Peggy
author_facet van der Plas, Ellen
Koscik, Timothy R.
Magnotta, Vincent
Cumming, Sarah A.
Monckton, Darren
Gutmann, Laurie
Nopoulos, Peggy
author_sort van der Plas, Ellen
collection PubMed
description OBJECTIVE: The goal of the study was to identify brain and functional features associated with premanifest phases of adult-onset myotonic dystrophy type 1 (i.e., PreDM1). METHODS: This cross-sectional study included 68 healthy adults (mean age = 43.4 years, SD = 12.9), 13 individuals with PreDM1 (mean age: 47.4 years, SD = 16.3), and 37 individuals with manifest DM1 (mean age = 45.2 years, SD = 9.3). The primary outcome measures included fractional anisotropy (FA), motor measures (Muscle Impairment Rating Scale, Grooved Pegboard, Finger-Tapping Test, and grip force), general cognitive abilities (Wechsler Adult Intelligence Scales), sleep quality (Scales for Outcomes in Parkinson's Disease–Sleep), and apathy (Apathy Evaluation Scale). RESULTS: Individuals with PreDM1 exhibited an intermediate level of white matter FA abnormality, where whole-brain FA was lower relative to healthy controls (difference of the estimated marginal mean [EMM(difference)] = 0.02, 95% confidence interval (CI) 0.01–0.03, p < 0.001), but the PreDM1 group had significantly higher FA than did individuals with manifest DM1 (EMM(difference) = 0.02, 95% CI 0.009–0.03, p < 0.001). Individuals with PreDM1 exhibited reduced performance on the finger-tapping task relative to control peers (EMM(difference) = 5.70, 95% CI 0.51–11.00, p = 0.03), but performance of the PreDM1 group was better than that of the manifest DM1 group (EMM(difference) = 5.60, 95% CI 0.11–11.00, p = 0.05). Hypersomnolence in PreDM1 was intermediate between controls (EMM(difference) = −1.70, 95% CI −3.10–0.35, p = 0.01) and manifest DM1 (EMM(difference) = −2.10, 95% CI −3.50–0.60, p = 0.006). CONCLUSIONS: Our findings highlight key CNS and functional deficits associated with PreDM1, offering insight in early disease course.
format Online
Article
Text
id pubmed-8075572
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Wolters Kluwer
record_format MEDLINE/PubMed
spelling pubmed-80755722021-04-27 Neurocognitive Features of Motor Premanifest Individuals With Myotonic Dystrophy Type 1 van der Plas, Ellen Koscik, Timothy R. Magnotta, Vincent Cumming, Sarah A. Monckton, Darren Gutmann, Laurie Nopoulos, Peggy Neurol Genet Article OBJECTIVE: The goal of the study was to identify brain and functional features associated with premanifest phases of adult-onset myotonic dystrophy type 1 (i.e., PreDM1). METHODS: This cross-sectional study included 68 healthy adults (mean age = 43.4 years, SD = 12.9), 13 individuals with PreDM1 (mean age: 47.4 years, SD = 16.3), and 37 individuals with manifest DM1 (mean age = 45.2 years, SD = 9.3). The primary outcome measures included fractional anisotropy (FA), motor measures (Muscle Impairment Rating Scale, Grooved Pegboard, Finger-Tapping Test, and grip force), general cognitive abilities (Wechsler Adult Intelligence Scales), sleep quality (Scales for Outcomes in Parkinson's Disease–Sleep), and apathy (Apathy Evaluation Scale). RESULTS: Individuals with PreDM1 exhibited an intermediate level of white matter FA abnormality, where whole-brain FA was lower relative to healthy controls (difference of the estimated marginal mean [EMM(difference)] = 0.02, 95% confidence interval (CI) 0.01–0.03, p < 0.001), but the PreDM1 group had significantly higher FA than did individuals with manifest DM1 (EMM(difference) = 0.02, 95% CI 0.009–0.03, p < 0.001). Individuals with PreDM1 exhibited reduced performance on the finger-tapping task relative to control peers (EMM(difference) = 5.70, 95% CI 0.51–11.00, p = 0.03), but performance of the PreDM1 group was better than that of the manifest DM1 group (EMM(difference) = 5.60, 95% CI 0.11–11.00, p = 0.05). Hypersomnolence in PreDM1 was intermediate between controls (EMM(difference) = −1.70, 95% CI −3.10–0.35, p = 0.01) and manifest DM1 (EMM(difference) = −2.10, 95% CI −3.50–0.60, p = 0.006). CONCLUSIONS: Our findings highlight key CNS and functional deficits associated with PreDM1, offering insight in early disease course. Wolters Kluwer 2021-03-18 /pmc/articles/PMC8075572/ /pubmed/33912661 http://dx.doi.org/10.1212/NXG.0000000000000577 Text en Copyright © 2021 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
spellingShingle Article
van der Plas, Ellen
Koscik, Timothy R.
Magnotta, Vincent
Cumming, Sarah A.
Monckton, Darren
Gutmann, Laurie
Nopoulos, Peggy
Neurocognitive Features of Motor Premanifest Individuals With Myotonic Dystrophy Type 1
title Neurocognitive Features of Motor Premanifest Individuals With Myotonic Dystrophy Type 1
title_full Neurocognitive Features of Motor Premanifest Individuals With Myotonic Dystrophy Type 1
title_fullStr Neurocognitive Features of Motor Premanifest Individuals With Myotonic Dystrophy Type 1
title_full_unstemmed Neurocognitive Features of Motor Premanifest Individuals With Myotonic Dystrophy Type 1
title_short Neurocognitive Features of Motor Premanifest Individuals With Myotonic Dystrophy Type 1
title_sort neurocognitive features of motor premanifest individuals with myotonic dystrophy type 1
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8075572/
https://www.ncbi.nlm.nih.gov/pubmed/33912661
http://dx.doi.org/10.1212/NXG.0000000000000577
work_keys_str_mv AT vanderplasellen neurocognitivefeaturesofmotorpremanifestindividualswithmyotonicdystrophytype1
AT kosciktimothyr neurocognitivefeaturesofmotorpremanifestindividualswithmyotonicdystrophytype1
AT magnottavincent neurocognitivefeaturesofmotorpremanifestindividualswithmyotonicdystrophytype1
AT cummingsaraha neurocognitivefeaturesofmotorpremanifestindividualswithmyotonicdystrophytype1
AT moncktondarren neurocognitivefeaturesofmotorpremanifestindividualswithmyotonicdystrophytype1
AT gutmannlaurie neurocognitivefeaturesofmotorpremanifestindividualswithmyotonicdystrophytype1
AT nopoulospeggy neurocognitivefeaturesofmotorpremanifestindividualswithmyotonicdystrophytype1